Linzess

Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Ironwood Pharmaceuticals
Allergan
Linzess
clinical trials
IBS-C
Flag link:
14 Drugs Earn Billions for These Massachusetts Biotechs
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Massachusetts
Boston
Biogen
Tecfidera
Benepali
Shire
Takeda
Vyvanse
Vertex Pharmaceuticals
Orkambi
Kalydeco
Alexion
Soliris
Strensiq
Sanofi Genzyme
Lantus
Ironwood Pharmaceuticals
Linzess
Flag link:
Ironwood, Allergan set to resolve LINZESS patent litigation with Mylan
Ironwood, Allergan set to resolve LINZESS patent litigation with Mylan
Pharmaceutical Business Review
Ironwood Pharmaceuticals
Mylan
patents
Linzess
Flag link:
Linzess Receives Additional Indication in Japan for Chronic Constipation
Linzess Receives Additional Indication in Japan for Chronic Constipation
CP Wire
Linzess
Astellas
Ironwood
chronic constipation
Flag link:
Linzess Receives Additional Indication in Japan for Chronic Constipation
Astellas
Ironwood Pharmaceuticals
Linzess
Flag link:
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
CP Wire
Ironwood Pharmaceuticals
Allergan
linaclotide
Linzess
IBS-C
Flag link:
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
Ironwood Pharmaceuticals
Allergan
linaclotide
Linzess
IBS-C
Flag link:
Allergan: Is Linzess 'Restasis 2.0'?
Allergan: Is Linzess 'Restasis 2.0'?
NY Shock Exchange
Allergan
Restasis
patents
Linzess
Ironwood Pharmaceuticals
Teva Pharmaceutical
IBS-C
Flag link:
3 Big Battles Brewing in Biotech
3 Big Battles Brewing in Biotech
Motley Fool
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira
Flag link:
Ironwood exec's brainstorm gives Allergan a marketing edge with Linzess
Ironwood exec's brainstorm gives Allergan a marketing edge with Linzess
Fierce Pharma Marketing
Ironwood Pharmaceuticals
Allergan
Linzess
Flag link:
Is This Ironwood Pharmaceuticals' Biggest Threat?
Is This Ironwood Pharmaceuticals' Biggest Threat?
Motley Fool
Ironwood Pharmaceuticals
Linzess
plecanatide
Synergy Pharmaceuticals
Flag link:
​Ironwood marks rare milestone: 1 million patients have taken Linzess
​Ironwood marks rare milestone: 1 million patients have taken Linzess
Bizjournals.com
Ironwood Pharmaceuticals
Linzess
IBS-C
Flag link:
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Seeking Alpha
Synergy Pharmaceuticals
IBS-C
plecanatide
Linzess
Ironwood
Flag link:
Next DTC push for Linzess: Spotlight patients, with big salesforce backup
Next DTC push for Linzess: Spotlight patients, with big salesforce backup
Fierce Pharma Marketing
Actavis
Ironwood
DTC
Linzess
IBS-C
Flag link:
Companies Betting on the Next 10 Blockbuster Drugs
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Flag link:
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Synergy Pharmaceuticals
IBS-C
Ironwood Pharmaceuticals
Linzess
Sucampo
plecanatide
Flag link:
The Compelling Science Behind Synergy
The Compelling Science Behind Synergy
Seeking Alpha
Synergy Pharmaceuticals
plecanatide
Ironwood
Linzess
Flag link:
Ironwood's Bowel Drug Sales Disappoint
Ironwood's Bowel Drug Sales Disappoint
TheStreet.com
Ironwood
Linzess
Forest Labs
irritable bowel syndrome
IBS
Flag link:
10 Drugs Approved by the FDA in 2012 to Be Thankful For
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Flag link:
Ironwood Pharma posts 3Q profit on drug approval
Ironwood Pharma posts 3Q profit on drug approval
Yahoo/AP
Ironwood Pharmaceuticals
earnings
Linzess
Flag link:

Pages